179 followers
RT @FrontEndocrinol: New Research: A systematic review of the safety of tirzepatide-a new dual GLP1 and GIP agonist - is its safety profile…
RT @FrontEndocrinol: New Research: A systematic review of the safety of tirzepatide-a new dual GLP1 and GIP agonist - is its safety profile…
New Research: A systematic review of the safety of tirzepatide-a new dual GLP1 and GIP agonist - is its safety profile acceptable?: Aims Tirzepatide is a novel dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like… https://t.co/xMuEfUVSsI